Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of Linical Co., Ltd.. A complete text table follows the diagram.
The packet has no additive segment table, so the consolidated income statement carries the story.
Swipe to explore
Every category amount is a reported EDINET XBRL fact. Nodes described as arithmetic bridges are calculated residuals and do not imply a separately reported filing line.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Cost of sales | 1 | 3.8B | 77.9% of reported total |
| Gross profit | 1 | 1.1B | 22.1% of reported total |
| Clinical-research sales converted into gross profit | 2 | 4.9B | Reported six-month total · ¥4.9B |
| Operating loss | 2 | 511M | Absolute value of reported operating loss |
| Operating costs & expenses | 3 | 5.4B | Revenue plus reported operating loss |
| From | To | Value |
|---|---|---|
| Cost of sales | Clinical-research sales converted into gross profit | 3.8B |
| Gross profit | Clinical-research sales converted into gross profit | 1.1B |
| Clinical-research sales converted into gross profit | Operating costs & expenses | 4.9B |
| Operating loss | Operating costs & expenses | 511M |